Oncogenic genomic alterations, clinical phenotypes, and outcomes in metastatic castration-sensitive prostate cancer

BACKGROUND: The genomic underpinning of clinical phenotypes and outcomes in metastatic castration-sensitive prostate cancer is unclear. METHODS: In patients with metastatic castration-sensitive prostate cancer at a tertiary referral center, clinical-grade targeted tumor sequencing was performed to q...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Cancer Res
Main Authors: Stopsack, Konrad H., Nandakumar, Subhiksha, Wibmer, Andreas G., Haywood, Samuel, Weg, Emily S., Barnett, Ethan S., Kim, Chloe J., Carbone, Emily A., Vasselman, Samantha E., Nguyen, Bastien, Hullings, Melanie A., Scher, Howard I., Morris, Michael J., Solit, David B., Schultz, Nikolaus, Kantoff, Philip W., Abida, Wassim
Formato: Artigo
Idioma:Inglês
Publicado: 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7334067/
https://ncbi.nlm.nih.gov/pubmed/32220891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-0168
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares